21.9 C
New York
Thursday, July 3, 2025

Tag: Other OTC:MEDIF

newssourcecompanyFORcontentinformation1marketbusiness

MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders

MediPharm Announces Election of All Seven Company Director Nominees at 2025 Annual and Special Meeting of Shareholders.

MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to respond to a misleading press release published earlier today by Apollo Technology Capital Corporation (“Apollo”) prematurely claiming that it considers the results of the annual and special meeting of shareholders scheduled to take place at 3:00 p.m. today (the “Meeting”) to be a clear victory for Apollo.

Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees

Independent proxy advisor Glass Lewis recommends that MediPharm shareholders vote for all of the Company's director nominees.

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline

MediPharm reminds shareholders to vote for proven strategy and team in advance of deadline, July 13, 2025 at 3:00pm EDT.

MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting

Ontario Superior Court of Justice fully dismisses application by dissident shareholder Apollo against MediPharm Labs.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOther OTC:MEDIF

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers